Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 170
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02621398 | Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer | ||
| NCT00496600 | Phase I Study of Patupilone and RAD001 | ||
| NCT02144701 | Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant | ||
| NCT04141449 | A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation | ||
| NCT00866840 | Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery | ||
| NCT06763770 | Digital Self-Management and Peer Mentoring Intervention | ||
| NCT00176579 | Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer | ||
| NCT00934895 | Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca | ||
| NCT00176631 | Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | ||
| NCT00770055 | Internet Use Among Women With Recurrent Metastatic Breast Cancer | ||
| NCT02458716 | Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer | ||
| NCT00295932 | Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma | ||
| NCT00138151 | Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer | ||
| NCT02117817 | Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer | ||
| NCT04929899 | Bright Ideas - CIN Feasibility Study | ||
| NCT03257163 | Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer | ||
| NCT01617161 | Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer | ||
| NCT00878657 | Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer | ||
| NCT00634634 | Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer | ||
| NCT01510119 | Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma | ||
| NCT00765765 | Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer | ||
| NCT00899808 | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer | ||
| NCT00996359 | Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation | ||
| NCT03108911 | Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy | ||
| NCT01982058 | Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer | ||
| NCT00176644 | Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer | ||
| NCT04445844 | INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study | ||
| NCT03233555 | Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer | ||
| NCT00966667 | Health Behaviors in Patients Who Have Finished Treatment for Stage I, Stage II, or Stage III Colorectal Cancer | ||
| NCT06927700 | Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes | ||
| NCT00943709 | Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia | ||
| NCT02949284 | Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery | ||
| NCT02250781 | Oral ONC201 in Treating Patients With Advanced Solid Tumors | ||
| NCT03061175 | Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy | ||
| NCT02699996 | Peer Mentoring in Promoting Follow-up Care Self-Management in Younger Childhood Cancer Survivors | ||
| NCT00101062 | Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | ||
| NCT00582829 | Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients | ||
| NCT00726596 | Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer | ||
| NCT00786682 | Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer | ||
| NCT02620527 | Concordance Between ctDNA Assay and FoundationOne | ||
| NCT03228147 | Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment | ||
| NCT03428802 | Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability | ||
| NCT01326286 | Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer | ||
| NCT00176462 | CINJALL: Treatment for Children With Acute Lymphocytic Leukemia | ||
| NCT04146038 | Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease | ||
| NCT03313492 | Modifying Young Adult Skin Cancer Risk and Protective Behaviors | ||
| NCT01828476 | Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer | ||
| NCT00895115 | Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer | ||
| NCT05785780 | Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings | ||
| NCT00118053 | Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer |
